Zoetis relaunches terramycin; Putney gets FDA approval;

> Zoetis' ($ZTS) terramycin, which is an opthalmic ointment used to treat superficial ocular infection and bacterial inflammatory conditions in dogs and cats, has been made available again to veterinarians after being off the market for two years. Announcement

> Putney got the go-ahead from the FDA for an abbreviated new animal drug application (ANADA) for meloxicam solution for injection for the control of pain and inflammation in dogs and cats. FDA Announcement (PDF)

> Veterinary diagnostic specialist Idexx Laboratories has selected UPS to provide third-party logistic services as part of its goal to go "all-direct" with U.S. companion animal veterinary practices. Announcement

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…